Cochleovestibular toxicity induced by immune checkpoint inhibition: a case series.

Autor: Lemasson J; Dermatology, AP-HP Hopital Saint-Louis, Paris, France., Cuzzubbo S; Neuro-Oncology, AP-HP Hopital Saint-Louis, Paris, France; Université de Paris, France., Doucet L; Medical Oncology, AP-HP Hopital Saint-Louis, Paris, France., Gounant V; Thoracic Oncology, AP-HP Hopital Bichat, Paris, France., Baroudjian B; Dermatology, AP-HP Hopital Saint-Louis, Paris, France., Herms F; Dermatology, AP-HP Hopital Saint-Louis, Paris, France., Carpentier AF; Neuro-Oncology, AP-HP Hopital Saint-Louis, Paris, France; Université de Paris, France., Lebbé C; Dermatology, AP-HP Hopital Saint-Louis, Paris, France; Université de Paris, INSERM HIPI, France., Vitaux H; Department of Otorhinolaryngology, Head & Neck Surgery, Hopital Lariboisière, Paris, France., Hautefort C; Department of Otorhinolaryngology, Head & Neck Surgery, Hopital Lariboisière, Paris, France., Delyon J; Dermatology, AP-HP Hopital Saint-Louis, Paris, France; Université de Paris, INSERM HIPI, France. Electronic address: julie.delyon@aphp.fr.
Jazyk: angličtina
Zdroj: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2019 Aug; Vol. 117, pp. 116-118. Date of Electronic Publication: 2019 Jul 03.
DOI: 10.1016/j.ejca.2019.05.022
Databáze: MEDLINE